Contrary to studies on the detection of bladder cancer, the number of urinary DNA methylation studies for prostate cancer is small; however, almost all studies analyzed the methylation status of GSTP1. Early studies suggested that GSTP1 methylation is a promising marker; however, a recent prospective study revealed it to have insufficient specificity. This evidence concerns the gene GSTP1 and prostate carcinoma.